POLARYX THERAPEUTICS INC

PLYX · NASDAQ

Updated at 2026-11-16 21:26:12

$1.67-5.64%
Today's High
$1.76
Today’s Low
$1.67
POLARYX THERAPEUTICS INC (PLYX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.88
Previous Close
$1.77
Volume
10.4K
Market Cap
$88.22M
P/E Ratio
--
EPS
$-0.11

Previous Day Range

$1.77$1.88

52-Week Range

$1.69$48.91

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
SOUTH TOWER, PARAMUS, NJ, UNITED STATES, 07652
Country
US
Listing Date
2026-02-02
Fiscal Year End
December
Shares Outstanding
49.85M
CIK
--

Polaryx Therapeutics, Inc., clinical-stage biotechnology company, develops small molecule and gene therapy treatments for lysosomal storage disorders. The company is headquartered in Paramus, New Jersey.

Financial Metrics

Revenue

2026-09-30

--

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

Operating Expenses

2026-09-30

$3.32M

2026-06-30

$1.38M

2026-03-31

$1.95M

2025-12-31

$911K

Net Income

2026-09-30

-$3.32M

2026-06-30

-$1.38M

2026-03-31

-$2.54M

2025-12-31

-$1.49M

Net Profit Margin

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

Earnings Per Share

2026-09-30

$-0.07

2026-06-30

$-0.03

2026-03-31

$-0.05

2025-12-31

$-0.16

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

-$3.32M

2026-06-30

-$1.38M

2026-03-31

-$2.54M

2025-12-31

-$1.49M

Effective Tax Rate

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.